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Morphine Postconditioning Attenuates ICAM-1 Expression on 
Endothelial Cells
The purpose of this study is to determine 1) whether morphine postconditiong (MPostC) 
can attenuate the intercellular adhesion molecules-1 (ICAM-1) expression after 
reoxygenation injury and 2) the subtype(s) of the opioid receptors (ORs) that are involved 
with MPostC. Human umbilical vein endothelial cells (HUVECs) were subjected to 6 hr 
anoxia followed by 12 hr reoxygenation. Three morphine concentrations (0.3, 3, 30 μM) 
were used to evaluate the protective effect of MPostC. We also investigated blockading the 
OR subtypes’ effects on MPostC by using three antagonists (a μ-OR antagonist naloxone, a 
κ-OR antagonist nor-binaltorphimine, and a δ-OR antagonist naltrindole) and the inhibitor 
of protein kinase C (PKC) chelerythrine. As results, the ICAM-1 expression was significantly 
reduced in the MPostC (3, 30 μM) groups compared to the control group at 1, 6, 9, and 
12 hours reoxygenation time. As a consequence, neutrophil adhesion was also decreased 
after MPostC. These effects were abolished by coadministering chelerythrine, nor-
binaltorphimine or naltrindole, but not with naloxone. In conclusion, it is assumed that 
MPostC could attenuate the expression of ICAM-1 on endothelial cells during 
reoxygenation via the κ and δ-OR (opioid receptor)-specific pathway, and this also involves 
a PKC-dependent pathway.
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INTRODUCTION
Reperfusion injury to endothelium is mediated by neutrophils 
that accumulate early after reperfusion in the previously isch-
emic cardiac tissue (1, 2). This neutrophil adhesion is made pos-
sible by the expression of adhesion molecules such as intercel-
lular adhesion molecule-1 (ICAM-1). The neutrophils adhered 
to the endothelial cells (ECs) potentiate the ischemic myocyte 
damage caused by microvascular obstruction and the genera-
tion of cytotoxic metabolites (1, 3).
  Postconditioning is a novel strategy for achieving cardiopro-
tection. It was first described by Zhao and colleagues in dogs (4), 
in which brief intermittent repetitive interruptions at the onset 
of reperfusion after a prolonged period of ischemia reduced the 
myocardial injury to an extent that was comparable to ischemic 
preconditioning (IPC), and IPC is a classic strategy for cardio-
protection. The beneficial outcomes observed with postcondi-
tioning include reducing an infarct’s size (4, 5), the endothelial 
dysfunction and the neutrophil adherence (4, 6) and the apop-
tosis (7). Wang et al. (8) demonstrated that morphine precondi-
tioning attenuated neutrophil activation in an isolated rat heart 
model via increasing the neural endopeptidase activities and 
the attenuated shedding of L-selectin and ICAM-1 via a μ-opioid 
receptor (OR)-specific pathway. They also reported that intra-
venous administration of morphine decreases the serum ICAM-
1 and L-selectin levels in acute myocardial infarction patients 
(9). This clinical setting seems to be similar to morphine post-
conditioning because the morphine was administered after the 
cardiovascular insult.
  From these observations, we hypothesized that morphine 
postconditioning (MPostC) could attenuate the expression of 
adhesion molecules such as ICAM-1 during an ischemic reper-
fusion period. In this study, we used in vitro ischemic cell cul-
ture system by using human umbilical vein endothelial cells 
(HUVECs) because the numerous possible confounding factors 
could influence vascular function in vivo system. We also inves-
tigated the mechanisms of MPostC by blocking OR subtypes’ 
effects on MPostC by using various antagonists.
 
MATERIALS AND METHODS 
Cell lines and Reagents
The human umbilical vascular endothelial cell (HUVEC) line (JG-
C2517A, single donor) is from Lonza and the medium is EGM
®-
2 BulletKit
® (CC-3162) from Lonza (Walkersville, MD, USA). The 
antibody is PE mouse anti-human CD54 from BD (cat. 555749; Min TJ, et al.  •  Morphine Postconditioning
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San Jose, California, USA), the RNeasy
® RNA isolation mini kit 
is from Qiagen (Hilden, Germany), and all the other reagents 
are from Sigma Chemicals (St. Louis, MO, USA).
Cell viability
Cell viability was measured by the cell counting method. First, 
the cells were removed from culture and separated into a test 
tube. The samples were diluted four times and then they were 
stained by trypan blue. The stained samples were set up by a 
hemocytometer and cover slipped, and then they were observed 
under low power microscopy. Finally the cells with an intact 
membrane were counted.
 
Anoxia/Reoxygenation
Anoxia was performed in an anaerobic chamber (model Inno-
va CO-14; New Brunswick Scientific, Hertfordshire, UK). To in-
duce abrupt anoxia, the cell culture medium was deoxygenated 
before the experiments by placing the cell culture in the cham-
ber for 12 hr. With this technique, the oxygen tension in the an-
oxic medium was 0.5 mmHg (i.e., > 99% decrease of the Po2). 
During periods of anoxia, the cells were kept in an incubator 
(37°C) within the anaerobic chamber. Reoxygenation was ob-
tained by removing the anoxic medium and changing it to a nor-
mal, oxygenated culture medium (95 mmHg) and by returning 
the ECs to the normal cell incubator.
Experimental protocols
MPostC was performed during 30 min and, after 6 hr anoxia, by 
using 0.3, 3, and 30 μM doses of morphine. The prolonged an-
oxia was set at 6 hr, and the ICAM-1 expression was evaluated 
at 0, 1, 3, 6, 9, and 12 hr reoxygenation (Fig. 1). The duration of 
anoxia was chosen based on a study by Beauchamp et al. (10), 
who showed a marginal increase of ICAM-1 after 6 hr anoxia, 
so we used 6 hr because it was the shortest anoxic time and the 
concentrations of morphine were chosen (0.3, 3.0, 30 μM) based 
on a study by Chen and Zhang. (11), who revealed the effect of 
MPostC in an isolated heart model, and Dershwitz et al.’s (12) 
clinical practice. The possible roles of ORs were evaluated: the 
cells were morphine (3 μM) postconditioned by coadminister-
ing the inhibitor of protein kinase C (PKC) chelerythrine (1, 5, 
25 μM) or the antagonist of the OR subtypes (nonselective, but 
highly affinitive μ-OR antagonist naloxone (2, 10, 50 μM), a κ-OR 
antagonist nor-binaltorphimine (1, 5, 25 μM) and a δ-OR antag-
onist naltrindole (1, 5, 25 μM)), and all dosages of the blockers 
were chosen based on previous studies (11, 13). The ICAM-1 ex-
pressions of blocker added groups were then compared to that 
of the control group at 6 hr reoxygenation time when the ICAM-
1 expression of the control group reached the peak value. 
Flow cytometry
The surface expressions of adhesion molecules were measured 
by flow cytometry (Facsflow from BD) by using an ICAM-1 spe-
cific fluorescein isothiocyanate–labeled antibody (BD, Franklin 
lake, NJ, USA). Briefly, the cells were washed with phosphate 
buffered saline (PBS) and then they were trypsinized. After de-
taching the cells and transferring them into tubes, the digestion 
was stopped by the addition of medium 199 that contained 10% 
fetal calf serum. After centrifugation at 218 g, (4°C, 5 min), the 
tubes were washed with PBS. The cells were incubated with PE 
Mouse Anti-Human CD54 for 30 min at 4°C, and the cells were 
washed again with PBS and resuspended in a volume of 500 μL 
PBS for the flow cytometric analysis. For the adjusting the in-
strument settings, the control cells were prepared by perform-
ing the procedure as described above, but by omitting addition 
of the antibody. At least three different sets of experiments with 
cells from different isolations were performed.
Assessment of the ICAM-1 gene expression by quantitative 
real-time PCR
RNA was prepared using an RNeasy
® RNA isolation Mini kit 
(Qiagen, Hilden, Germany). Reverse-transcription polymerase 
chain reaction (RT-PCR) was performed using a one-step RT-
PCR kit from Roche. The RT-PCR experiments were performed 
with the primers for the respective target enzyme ICAM-1: 5´- 
AGT-GGT-GGG- GGA-GAC-ATA-GC-3´ (sense); 3´-GTG-TGG-
GCC-TTT- GTG-TTT-TG-5´ (antisense). The conditions were as 
follows: ICAM-1:1 cycle at 95°C for 10 min; 50 cycles (for quan-
titative real-time PCR or qRT-PCR) at 95°C for 15 sec, 55°C for       
5 sec and 72°C for 6 sec; 1 cycle at 65°C for 15 sec and a final ex-
tension cycle at 40°C for 30 sec. The specificity of the qRT-PCR 
amplification was verified by a melting curve analysis (from 
50°C to 90°C) using SYBR Premix Ex Taq (Roche Diagnostic, 
Mannheim, Germany). The relative gene expression levels were 
calculated as ratios with using β-actin for normalization.
Neutrophil adhesion
The adhesion of neutrophils was assessed by using human neu-
trophils. The neutrophils were taken from healthy volunteers. 
The neutrophils were isolated with the use of the MiniMACS
TM 
Anoxia
Co-administration of selective 
blockers with morphine during 
MPostC
Reoxygenation
Reoxygenation
6 hr
Control group
MpostC group
6 hr 30 min
12 hr
12 hr
Anoxia MPostC
Fig. 1. Experimental protocol. MPostC represents morphine postconditioning.Min TJ, et al.  •  Morphine Postconditioning
292   http://jkms.org DOI: 10.3346/jkms.2011.26.2.290
Separator (Miltenyl Biotec, Bergisch Gladbach, Germany) and 
they were suspended in DMEM with 10% serum. The cell via-
bility, assessed with Trypan blue, was always > 96%. The suspen-
sion of neutrophils was then incubated with reoxygenated ECs 
at 6 hr reoxygenation under static conditions for 15 min at 37°C. 
After the dishes were washed with PBS, they were incubated with 
PE Mouse Anti-Human CD15 for 20 min at 4°C. Then they were 
fixed with 2% paraldehyde, and examined by optical microsco-
py (Carl Zeiss Ins., Berlin, Germany). The adherent neutrophils 
were counted on a minimum of 5 microscopic fields. The results 
are expressed ratio of adhesion of neutrophils to the ECs. 
Statistical analysis
We used SPSS for Windows version 10.0 (SPSS, Chicago, IL, 
USA) for the statistical analysis. All the data, which is expressed 
as means ± SDs, is representative of six different experiments. 
The results for the flow cytometry were evaluated by a one-way 
ANOVA. Comparisons between individual data were made us-
ing the paired t-test. All P values < 0.05 were considered signifi-
cant. 
RESULTS 
Cell viability
The cell survival rate after prolonged anoxia followed by reoxy-
genation was 92%. This was calculated as a mean value. 
The ICAM-1 expression on the HUVEC cells after 
reperfusion ischemic injury
ICAM-1 protein expression was measured each different dosage 
of MPostC (0.3, 3, 30 μM) groups in consecutive order. As dem-
onstrated in Fig. 2, the ICAM-1 protein expression was attenu-
ated at 1, 6, 9, and 12 hr in the 3 and 30 μM MPostC groups, as 
compared to that of the control group. There was no significant 
difference between the control group and the 0.3 μM group.
Neutrophil adhesion to ECs after reperfusion ischemic 
injury
The neutrophil adhesion to ECs was increased in the control 
group at 6 hr reoxygenation when a peak response of ICAM-1 
expression had been observed, as compared to that of the con-
trol group at 0 hr reoxygenation (baseline). Ischemia induced 
neutrophil adhesion to ECs of all groups was compared at 6 hr 
reoxygenation. The neutrophil adhesion to ECs was reduced in 
the 3 and 30 μM MPostC group as compared to that of the con-
trol group (Fig. 3). 
ICAM-1 mRNA synthesis after reperfusion ischemic injury
Ischemia induced messenger RNA (mRNA) expression of ICAM-
Concentration of morphine (µM)
Fig. 3. Ratio of adhesion neutrophils to ECs. The ratio of adhesion neutrophils to ECs 
was measured at 6 hr reoxygenation. Baseline meant the value of the control group 
at 0 hr reoxygenation. The valus are the mean ± SD of 6 experiments. *is P < 0.05.
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Fig. 2. Attenuation of the ICAM-1 protein expression in the HUVEC cells by MPostC. (A) The intercellular adhesion molecules-1 (ICAM-1) expression in the HUVECs is compared 
between the morphine postconditioning (MPostC) groups and the control group after 6 hr anoxia. The numbers of viable cells was 1 × 10
5 and the cell viability was 92%. The 
groups were divided to the control group and the 0.3, 3, and 30 μM MPostC groups. The mean fluorescence index (MFI) from each group was recorded at 0, 1, 3, 6, 9, and 12 hr. 
The valus are the mean ± SD of 6 experiments. *P < 0.05. (B) Phenotypical graph of the HUVECs. Flow cytometry analysis was done to characterize the ICAM-1 expressions 
on the HUVECs. PE Mouse Anti-Human CD54 monoclonal antibody was used to detect the ICAM-1 expression. The isotype antibody was used as the negative control (bold). 
The values were measured at 6 hr reperfusion time.
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1 of all groups was compared at 6 hr reoxygenation. mRNA ex-
pression of ICAM-1 was decreased in the 3, 30 μM MPostC groups 
as compared to that of the control group (Fig. 4).
ICAM-1 expression of the MPostC (3 μM) group with 
added selective blockers
The ICAM-1 protein expressions of the MPostC (3 μM) group 
with added selective blockers were measured at 6 hr reperfu-
sion time. As demonstrated in Fig. 5, the ICAM-1 protein ex-
pression was increased in the chelerythrine (25 μM) + MPostC 
(3 μM) group, the naltrindole (25 μM) + MPostC (3 μM) group 
and the nor-binaltorphimine (25 μM) + MPostC (3 μM) group, 
as compared to that of the 6 hr MPostC (3 μM) group.
 
DISCUSSION
We observed that the expression of ICAM-1 on ECs and neutro-
phil adhesion to ECs were attenuated by MpostC during reoxy-
genation period. The effect of MpostC was abolished by selec-
tive blockers (the inhibitor of PKC chelerythrine, κ-OR antago-
nist nor-binaltorphimine or δ-OR antagonist naltrindole).
  Clinically, it is difficult to apply ischemic postconditioning. 
Pharmacological postconditioning, which only requires that a 
drug that is given as adjunctive treatment be present could be 
readily applied to all clinical scenarios of myocardial ischemia-
reperfusion and this is a particularly promising therapy (14). 
Intravenous administration of morphine remains an essential 
step in the initial treatment of acute myocardial infarction (15) 
and it is usually injected after the ischemic insult. Since Zhao et 
al. (4) first described the cardioprotective effect of postcondi-
toning, the mechanism and effect of postconditiong have been 
studied in many articles (5, 6, 11, 14). Wang et al. (8) recently 
showed that posttreatment with morphine may decrease the 
size of infarction by mimicking ischemic postconditioning in 
the isolated rat heart, and both the mito-KATP channels and the 
κ-ORs, but not the δ-ORs, mediated the cardioprotection pro-
duced by MPostC. However, the effect of MPostC on ECs has 
not yet been investigated, and so our study is the first that has 
demonstrated the effect of MPostC on ECs.
  ICAM-1 is known to be a major ligand on ECs for the adhe-
sion of activated leukocytes and the subsequent passage of leu-
kocytes into the myocardium (16-18). The serum ICAM-1 levels 
are elevated in the patients with acute myocardial infarction, 
and this suggests that both rolling and postrolling events play 
an important role in ischemic myocardial injury (19). The ex-
pression of ICAM-1 can be induced by an inflammatory stimu-
lus, and it is particularly responsive to tumor necrosis factor-α 
(TNF-α) and interleukin-1 (20). Nuclear factor-κB is a latent gene 
regulatory protein (21) that is sequestered, in an inactive form, 
in the cytoplasm of most cells. Nuclear factor-κB has been im-
plicated in most inflammatory responses. After being activated, 
this protein upregulates the genetic expression of ICAM-1, among 
Concentration of morphine (µM)
Fig. 4. Attenuation of the ICAM-1 mRNA level in the HUVEC cells by MPostC. qRT-
PCR was performed to measure the ICAM-1 mRNA levels with using SYBR Premix Ex 
Taq. The relative gene expression levels were calculated as ratios by using β-actin for 
normalization. The value of the 0 hr control was baseline and it was calculated as a 
ratio of 1, and the others were recalculated as ratios relevant to a ratio of 1. All the 
values were compared to the value of the control group at 6 hr reoxygenation. The 
values are the mean ± SD of 6 experiments. *P < 0.05. 
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Fig. 5. Selective OR antagonists reverse the attenuation of the ICAM expression induced by MPostC. The intercellular adhesion molecule-1 (ICAM-1) expression was measured 
in the 3 μM morphine postconditioned cells in the presence of various concentrations of selective blockers. The mean florescence index of ICAM-1 was measured at 6 hr 
reoxygenation time. The dosages of each of the blockers were increased five folds at each time. The value of the control group at 0 hr reoxygenation was baseline and it was 
calculated as a ratio of 1, and the others were recalculated as ratios relevant to a ratio of 1. All the values were compared to the value of the 3 µM MpostC. The valus are the 
mean ± SD of 6 experiments. *P < 0.05.
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various other proinflammatory mediators. The ICAM-1 expres-
sion also could be increased by reactive oxygen species (22) and 
this was supported by Beauchamp et al.’s experiment (10). As 
demonstrated in Fig. 2, the effects of MPostC seemed to reach 
their maximum at 3 μM, and the increment of the morphine dos-
age (30 μM) did not further attenuate the ICAM-1 expression. 
This suggests that MPostC might have a ceiling effect when mor-
phine over 3 μM is used for postconditioning. Hsiao et al. (23) 
reported that apoptosis was increased in HUVEC cells when 
they were incubated with more than 10 μM morphine through-
out 48 to 72 hr period. In this study, we treated the HUVEC cells 
with 0.3, 3, 30 μM morphine in a period of 30 min, and we did 
not observe a further decrease of cell viability after morphine 
postconditioning.
  Ichikawa et al. (24) reported that the neutrophil adherence to 
ECs was increased after 1 hr anoxia, and they showed a bipha-
sic increase in neutrophil adhesion to HUVECs, with the peak 
responses occurring at 30 min (phase 1) and 4 hr after reoxygen-
ation (phase 2). This two-phase neutrophil–EC adhesion re-
sponse involved the transcription-independent (phase 1) and 
transcription-dependent (phase 2) surface expression of differ-
ent EC adhesion molecules. In our study, the ICAM-1 expres-
sion showed a monophasic pattern, with a peak response oc-
curring at 6 hr reoxygenation. 
  Although several endothelial adhesion molecules might be 
involved in the neutrophil adhesion to ECs (for example P and 
E selectins), Yoshida et al. (25) reported increment of reperfu-
sion-induced neutrophil-endothelial interactons was mediated 
through the interacton between neutrophil and ICAM-1. We also 
confirmed that the neutrophil adhesion to ECs was increased 
in the control group at 6 hr reoxygenation as compared to the 
control group at 0 hr reoxygenation (Fig. 3). These results strong-
ly supported that the upregulated ICAM-1 expression increased 
neutrophil adhesion to ECs. Therefore it is important to attenu-
ate the ICAM-1 expression for reducing neutrophil induced isch-
emic reperfusion injury to the endothelium. We also confirmed 
that neutrophil adhesion to ECs was attenuated by MPostC (Fig. 
3), and the mRNA expression of ICAM-1 was decreased in the 3 
and 30 μM MPostC groups, as compared to that of the control 
group (Fig. 4). The mRNA expression of ICAM-1 was similar to 
phase 2 of a previous study (24). This suggests that MPostC may 
attenuate the ICAM-1 expression at 6 hr reoxygenation by a tran-
scription-dependent mechanism.
  The OR family is comprised of three primary subtypes: µ, κ, 
and δ. The ORs are guanine nucleotide binding protein (G pro-
tein)-coupled receptors that inhibit adenylyl cyclase (Gi cou-
pled). Both OR activation, which has been implicated in IPC, 
and the exogenous activation of ORs have been well document-
ed to confer both acute and delayed cardioprotection against 
ischemia-reperfusion injury (26). The mechanisms by which 
OR activation confers cardioprotection are typically thought to 
involve the phosphatidylinositol 3-kinase, MAPK (mitogen-ac-
tivated protein kinases), PKC (protein kinase C) and GSK3-path-
ways (26, 27), as well as both the sarcolemmal and mitochon-
drial ATP-sensitive K (mitoKATP) channels (26). Fu et al. (28) 
revealed the cardioprotective effects of IPC in isolated rat hearts 
via the κ-ORs and δ-ORs. Zhang et al. (29) suggested that the 
remifentanil-conferred myocardial protection against ischemic 
injury occurred through a mechanism that was similar to IPC 
and the involved PKC pathway; Peart and Gross (30) described 
that chronic morphine preconditioning was mediated by a PKC-
independent pathway, and this involved PKA, β2-AR and Gs pro-
teins, whereas acute morphine preconditioning was mediated 
via the Gi proteins and the PKC pathway. Wang et al. (8) first re-
ported the effect of morphine preconditioning on ECs. They re-
vealed that in an isolated rat heart model, morphine precondi-
tioning with naloxone (a µ-OR antagonist) abolished the car-
dioprotective effect and increased the ICAM-1 expression. But 
chelerythrine (a PKC inhibitor) or glibenclamide (an ATP-sen-
sitive potassium channel antagonist) did not alter the action of 
morphine preconditioning on the neutrophil-endothelium ac-
tivation. Thus, they concluded that morphine preconditioning 
attenuated the ICAM-1 expression via a µ-OR-specific pathway. 
Further, they reported that morphine preconditioning did not 
involve the PKC pathway or the ATP-sensitive potassium chan-
nels. That was different from the opioid preconditioning path-
way for the cardiomyocytes, which was thought to be related to 
the κ-OR and δ-OR pathways (15, 26, 30), with involvement of 
the PKC pathway.
  As demonstrated in Fig. 5, the ICAM-1 protein expression was 
increased in the chelerythrine, naltrindole or nor-binaltorphi-
mine + MPostC (3 μM) groups. This result means that κ-OR and 
δ-OR could be involved in the effects of MPostC on the ICAM-1 
expression instead of µ-OR, which is unlike the pathway of mor-
phine preconditioning that was previously described (8). Wang 
et al. (8) reported that morphine preconditioning increases the 
activities of neutrophil endopeptidase to attenuate ICAM-1 via 
a μ-opioid receptor-specific pathway. However Chen et al. (11) 
concluded that morphine postconditioning protected isolated 
rat hearts via both the mito-KATP channel and κ-OR but not δ-OR, 
yet Gross et al. (27) demonstrated that BW373U86 (a selective 
δ-OR ligand) conferred protection when administered at reper-
fusion in isolated rat hearts. Although there have been conflicts 
and debates about the mechanism of morphine postcondition-
ing, on the basis of our observations, we believe that the effects 
of MPostC on the ICAM-1 expression of ECs could be mediated 
by both κ and δ-ORs, and it also involves a PKC-dependent path-
way. However, it is still remained to determine whether block-
ade of MPostC was mimicked by direct effects of antagonists. 
Therefore, we plan to enhance understanding of antagonists’ 
direct effects to ICAM-1 expression by using the siRNA blocking 
or knock-out mice in a future study. Min TJ, et al.  •  Morphine Postconditioning
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  In conclusion, MPostC could attenuate the expression of 
ICAM-1 on ECs during reoxygenation period via the κ and δ-OR 
(opioid receptor)-specific pathway, involving a PKC-dependent 
pathway.
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In this study we demonstrated that MPostC attenuates the expression of ICAM-1 on endothelial cells and the neutrophil adhesion 
to Endothelial cells. Our results suggest that the inhibitory effects of MPostC on the ICAM-1 expression of ECs could be mediated 
by both κ and δ-Ors. Also, a PKC-dependent pathway appears to be involved.